TIAA CREF Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$1.29M Sell
66,345
-3,767
-5% -$73.5K ﹤0.01% 2202
2018
Q4
$925K Sell
70,112
-2,054
-3% -$27.1K ﹤0.01% 2315
2018
Q3
$1.28M Sell
72,166
-40,869
-36% -$727K ﹤0.01% 2330
2018
Q2
$2.49M Buy
113,035
+93,746
+486% +$2.06M ﹤0.01% 2050
2018
Q1
$426K Buy
19,289
+3,460
+22% +$76.4K ﹤0.01% 2809
2017
Q4
$343K Buy
+15,829
New +$343K ﹤0.01% 2910